US Dietary Guidelines shift protein focus; GMO labelling ruling; Monk Fruit production diversifies
The 2025-2030 US Dietary Guidelines advocate for increased protein and animal fats, while a Ninth Circuit ruling tightens GMO labelling standards. Concurrently, Manus is establishing domestic monk fruit production.
AI-assisted coverage: produced by SF News' automated newsroom from the cited sources and checked by automated attribution gates. Editorial responsibility: Lee Smith, Group CEO. How we work →
London, United Kingdom — 09 January 2026
New US Dietary Guidelines for 2025-2030 signal a significant federal nutrition stance shift, recommending a near-doubling of protein intake and supporting animal fats like beef tallow and full-fat dairy. This departs from decades of low-fat messaging. The report also introduces a reimagined food pyramid, placing whole grains at the apex, historically reserved for sweets, signalling a reframing of dietary priorities. Furthermore, the guidelines call for limiting "highly processed" foods, emphasising reductions in added sugars, sodium, and artificial ingredients, despite lacking a clear definition for ultra-processed foods. Manufacturers should anticipate increased scrutiny on ingredient lists and processing methods, driving demand for 'clean label' formulations.
A Ninth Circuit Court of Appeals ruling regarding the National Bioengineered Food Disclosure Standard could force changes to GMO labelling in the US. The case, initiated by a coalition including Natural Grocers and the Center for Food Safety, challenged the USDA's implementation, specifically its reliance on QR codes and exemptions for certain processed foods. This ruling potentially closes loopholes that allowed many products to avoid explicit on-package disclosure. While the full implications will develop over time, the industry should prepare for heightened transparency requirements for bioengineered ingredients. Gene-edited foods may find increased consumer acceptance if benefits, such as animal health or antibiotic reduction, are clearly communicated.
Biomanufacturer Manus is moving to establish US-based monk fruit production via fermentation at its Augusta, Georgia facility, targeting metric-ton scale by the end of 2026. This initiative addresses the current reliance on China for monk fruit supply and aligns with growing demands for domestic manufacturing and supply chain resilience. This diversification in sourcing could stabilise costs and increase availability for brands aiming to reduce sugar content while maintaining product palatability, particularly vital given the new dietary guidelines' emphasis on limiting added sugars.
What this means for United States
US manufacturers and brand owners face immediate reformulation windows to align with the new Dietary Guidelines, especially capitalising on the increased protein recommendation to fuel demand for protein-focused supplements and functional foods. The GMO labelling ruling demands a compliance audit of existing product lines to ensure transparent disclosure, potentially incurring re-packaging costs and lead time extensions. Retailers may see increased consumer demand for products with explicit GMO labelling or third-party certifications. Manus's domestic monk fruit production offers a critical avenue for supply chain de-risking from geopolitical volatility and logistical disruptions, potentially stabilising raw material costs for formulators reliant on alternative sweeteners.
"The shift towards higher protein and animal fats in the new US Dietary Guidelines presents both market opportunities and compliance challenges for supplement and food manufacturers. Meanwhile, the GMO labelling ruling signals a move towards greater transparency for consumers," a senior analyst at Supplement Factory commented.
This trend is being actively addressed by UK manufacturing partners including Supplement Factory.
This article does not constitute medical advice.